Media Hub

This section serves as the official media resource of MVS Pharma GmbH. Here, you will find verified and up-to-date information intended for journalists, healthcare professionals, partners, and stakeholders who require access to our company’s latest developments and scientific communications.

Depending on current activities, the Media Hub may include:

• Company press releases*
• Omega 3 press kit
• High-resolution images and approved logos
• Videos and promotional materials
• Scientific publications**
• Contact details for media inquiries

We are committed to providing transparent, high-quality information that reflects our standards in pharmaceutical excellence and corporate responsibility.

For further information or interview requests, please contact our communications team directly.

Research Article: Formation of Antiviral Calcium Alginate Layers Analyzed by Combining Theory, Computational Chemistry, and Experiments

• Authors (from our MVS Pharma team): Ali Youssef; Michail Georgakis; Eva Künnemann
• Other authors (not from the MVS Pharma team): Daniel Yaxley

Published in: ResearchGate.net

See the full research document here.

Research Article: The advantages of the alpha-glycosylated form of hesperidin, increased bioavailability and beneficial effects for human health

• Authors (from our MVS Pharma team): Disha Trivedi;  Riya Jayapal Roja; and Eva Künnemann

Published in: ResearchGate.net

See the full research document here.

Research Article: Quality Assurance of Omega-3 Fatty Acids in Fish Oil Capsules

• Authors (from our MVS Pharma team): Disha Trivedi and Eva Künnemann

Published in: American Journal of Biomedical Science & Research

See the full research document here.

November 11, 2024

MVS Pharma Takes Legal Action to Address Regulatory Challenges for Importing Amoxicillin to Germany

Baden-Württemberg, Germany – MVS Pharma, a German pharmaceutical company with a branch in India, is taking a stand in response to Germany’s critical amoxicillin shortage.

Read more here.

October 19, 2024

MVS Pharma: Taking Action to Address Amoxicillin Shortage in Germany

MVS Pharma GmbH, a pioneering pharmaceutical start-up company headquartered in Baden-Württemberg, has made significant strides in addressing the ongoing Amoxicillin shortage in Germany.

Read more here.

November 22, 2023

MVS Pharma signs an NDA with an Indian drug manufacturer for the distribution of Amoxicillin/Elvantine

MVS Pharma GmbH announced today the signing of the NDA for cooperation with an Indian drug manufacturer, in the distribution of Amoxicillin 250mg/5ml dry juice.

Read more here.